Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
DNA methylation biomarkers-based pan-cancer classifier: predictive modeling for cancer classification.
PMID 42152108 · PMC13185202 · Genome medicine · 2026 · 8 claims · 5 setups
Relatively simple ML models (logistic regression) outperform complex algorithms such as deep neural networks for methylation-based cancer classification
-
Full-text index only
Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactions.
PMID 39759507 · PMC11695424 · Frontiers in immunology · 2024 · 8 claims · 8 setups
A malignant cell subtype in PCa with high expression of NEFH was identified, located at the differentiation terminal, showing higher malignancy and association with advanced tumor lesions.
-
Full-text index only
Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease.
PMID 41794040 · PMC13006398 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
CSF exhibits distinct, disease-specific immune landscapes across CNSL, BrMs, and GB-associated LMD
-
Full-text index only
Development and validation of an oxidative phosphorylation based prognostic model revealing tumor progression and immune microenvironment in lung adenocarcinoma.
PMID 41670771 · PMC12996521 · Discover oncology · 2026 · 8 claims · 8 setups
OXPHOS activity is significantly elevated in LUAD tumor tissue compared to adjacent normal tissue